9 June 2026
Latham & Watkins Advises Carlyle and SEB on Financing the Acquisition of Sangro Medical
Advising firms
Deal team
7 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Thomas Weitkamp Lead | Latham & Watkins LLP | Partner | Banking & Private Credit | Not stated |
| Christian Jahn | Latham & Watkins LLP | Partner | Not stated | Not stated |
| Martina Eisgruber | Latham & Watkins LLP | Counsel | Not stated | Not stated |
| Philipp Guggeis | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Stephan Hufnagel | Latham & Watkins LLP | Partner | Not stated | Munich |
| Corinna Freudenmacher | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Ulf Kieker | Latham & Watkins LLP | Partner | tax | Not stated |
4 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Not stated
- Counterparties
- Axcel (Buy-side)
Sangro Medical (Target)
Carlyle (Lenders)
SEB (Lenders)